advertisement
Ueno M 21
Showing records 1 to 21 | Display all abstracts from Ueno M86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Maruyama Y
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Maruyama Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Nakano Y
Cell Death and Disease 2020; 11: 166
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Ikeda Y
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Ikeda Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Hirooka K
Cell Death and Disease 2020; 11: 166
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Mori K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Chiba Y
Cell Death and Disease 2020; 11: 166
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Mori K
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Yoshii K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Ueno M
Cell Death and Disease 2020; 11: 166
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshii K; Ueno M
British Journal of Ophthalmology 2021; 105: 169-173
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Ojima D
Cell Death and Disease 2020; 11: 166
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Ueno M; Sotozono C
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshikawa H
British Journal of Ophthalmology 2021; 105: 169-173
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Hossain MR
Cell Death and Disease 2020; 11: 166
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Sotozono C
British Journal of Ophthalmology 2021; 105: 169-173
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Takahashi H
Cell Death and Disease 2020; 11: 166
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Kinoshita S
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Kinoshita S
British Journal of Ophthalmology 2021; 105: 169-173
86335 Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Yamamoto T; Kiuchi Y
Cell Death and Disease 2020; 11: 166
